Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial

Meghan Karuturi, Anas Younes, Luis Fayad, Larry Kwak, Barbara Pro, Jatin Shah, Yasuhiro Oki, Rinata Simien, Mary Joy Liboon, Toni Hutto, Lei Feng, Sandra Horowitz, Yago Nieto, Paolo Anderlini, Amin Alousi, Uday Popat, L. Jeffrey Medeiros, Roberto Miranda, Michelle Fanale*

*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial'. Together they form a unique fingerprint.